Both self-imposed prevention measures such as hand-washing, mask-wearing and social distancing, as well as government-imposed social distancing can help mitigate and delay a COVID-19 epidemic, according to a new study published this week in PLOS Medicine by Alexandra Teslya of University Medical Center Utrecht, Utrecht, The Netherlands and colleagues.
It seems there will never be enough “thank you’s” for the incredible doctors, nurses, technicians and support staff members who are working around the clock to help patients who have COVID-19, the dangerous coronavirus disease. The dedication, determination and spirit enable Johns Hopkins to deliver the promise of medicine.
Researchers at the George Washington University and Albert Einstein College of Medicine published a review in the journal Nitric Oxide suggesting that nitric oxide treatment can be pivotal in the fight against SARS-CoV-2.
A multi-disciplinary team of Rutgers professors have developed the COVIDNearby app that allows individuals to report coronavirus symptoms with an assurance of privacy.
Researchers at The Rockefeller University in New York have developed new tools to rapidly test the ability of antibodies to neutralize SARS-CoV-2, the novel coronavirus responsible for the COVID-19 pandemic. The approach, described today in the Journal of Experimental Medicine (JEM), will help researchers understand whether patients are susceptible to reinfection by SARS-CoV-2 and assess the effectiveness of experimental vaccines, as well as develop antibody-based therapies against the disease.
Thomas J. Bollyky, senior fellow for global health, economics, and development, and director of the Global Health Program at CFR, discusses the resurgence of COVID-19 cases and the effects of reopening economies around the world.
Medical experts support the ongoing protests against racist police killings and brutality, but experts do also worry these protests could increase coronavirus spread.
Dr. Terry Adirim provides answers to some of the most frequently asked questions regarding COVID-19 and return to school for school-age children. Adirim is a physician executive with senior leadership and executive experience in academic medicine and the federal government. Her expertise includes pandemic planning and response, health care quality improvement and patient safety, and health policy and management.
Researchers from the UCLA Fielding School of Public Health found deaths related to COVID-19‒associated conditions do not occur randomly in the state’s population; they occur more in some racial/ethnic (R/E) populations than in others.
Engineers have incorporated a new understanding of the impact of environmental factors on droplet spread into a mathematical model that can be used to predict the early spread of respiratory viruses including COVID-19, and the role of respiratory droplets in that spread.
Timothy Albertson has received a BARDA grant to lead a new clinical trial at UC Davis Health. The trial evaluates the efficacy, safety and tolerability of an antibody cocktail in hospitalized adult patients with COVID-19.
As supply shortages continue to hamper COVID-19 testing, AACC President Dr. Carmen Wiley explains how pooled testing could enable clinical labs to process more tests while saving the materials needed to run them.
Scientists and historians working at McMaster University, the Mütter Museum and the University of Sydney have pieced together the genomes of old viruses that were used as vaccination strains during and after the American Civil War ultimately leading to the eradication of smallpox.
Kony Chacon credits a century-old treatment now being used to help coronavirus patients fight off the infection – convalescent blood plasma transfusions – with helping her recover.
Private radiology practices have been especially hard hit by the COVID-19 pandemic, and the steps they take to mitigate the impact of the pandemic on their practice will shape the future of radiology, according to a special report from the Radiological Society of North America (RSNA) COVID-19 Task Force, published today in the journal Radiology.
The University of Miami Miller School of Medicine has been selected to be part of the National Institutes of Health COVID-19 Prevention Trials Network (CoVPN) to launch clinical trials to test investigational COVID-19 vaccines.
A new study by Kansas State University researchers is the first to confirm that SARS-CoV-2 cannot be transmitted to people by mosquitoes.
Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right